Progestogens, progesterone, coagulation and endothelium dependent response;Progestatifs, progestérone, coagulation et tonus vasculaire

Gynecologie Obstetrique et Fertilite

Volumn 30, Issue 5, 2002, Pages 421-426

  Schved, J F ^a,b   Biron, C ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b NONE

Author keywords

Contraception; Nitric oxide; Progestogens; Thrombosis; Vasodilatation

Indexed keywords

BLOOD CLOTTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTRADIOL; ESTROGEN; GESTAGEN; PROGESTERONE; PROTHROMBIN;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTRACEPTION; ENDOTHELIUM; FEMALE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; VEIN DISEASE;

EID: 0036080785     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00344-2     Document Type: Article

References (30)

1. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications
2. Risk of idiopathic venous thromboembolism in users of progestagens alone
3. Collaborative study of cardiovascular disease and steroid hormone contraception. Effects of different progestogens in low estrogen oral contraceptives on thromboembolic disease
4. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
5. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V leiden mutation
6. Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and haemostatic parameters in premenopausal women
7. Effect of oral contraceptives on haemostasis variables
8. Effects of three types of combined oral contraceptive pills on blood coagulation, fibrinolysis and platelet function
9. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study
10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis. A randomized cross-over study of two low-dose oral contraceptives
11. A randomized cross-over study on the effect of levonorgestrel - And desogestrel - Containing oral contraceptives on the anticoagulant pathways
12. Acquired APC resistance and oral contraceptives: A randomized cross-over study of two low dose oral contraceptives
13. Effects on haemostatic variables of désogestrel - And gestodene - Containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review
14. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebocontrolled 12-week study
15. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
16. Effect of estrogens on the uterine blood flow of oophorectomized ewes
17. Estrogen modulates responses of atherosclerotic coronary arteries
18. Effect of 17 beta-œstradiol on endothelium-dependent responses in the rabbit
19. Nitric oxide release accounts for the biological activity of the endothelium-derived relaxing factor
20. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis
21. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
22. Nitric oxide accounts for dosedependent estrogen- mediated coronary relaxation after estrogen withdrawal
23. 17 Beta estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease
24. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries
25. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus Monkeys
26. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
27. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro
28. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone
29. Inhibition of the protective effect by progesterone in experimental atherosclerosis
30. Progesterone inhibits arterial smooth muscle cell proliferation